Vireo is currently in early access and completely free. The first 100 subscribers keep the founding-member price permanently: €3/month (normally €5).
Vireo
/

David Augustsson — Management

Get alerts when David Augustsson trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Oncopeptides AB.

12-month summary

No open-market buys or sales in the last 12 months

0 open-market buys, 0 sales, 2 share awards

Roles

Oncopeptides AB Stockholm
Management
25.08.2025 – 17.03.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
17.03.2026Oncopeptides AB Stockholm
New shares (subscription)
1,872SEK 1.53
SEK 2,864.16
↗
17.03.2026Oncopeptides AB Stockholm
New shares (subscription)
6,756SEK 1.53
SEK 10,336.68
↗
17.03.2026Oncopeptides AB Stockholm
New shares (subscription)
4,681SEK 1.53
SEK 7,161.93
↗
17.03.2026Oncopeptides AB Stockholm
New shares (subscription)
1,070SEK 1.53
SEK 1,637.10
↗
16.03.2026Oncopeptides AB Stockholm
Share award
66—
Share award
66 units
↗
16.03.2026Oncopeptides AB Stockholm
Share award
456—
Share award
456 units
↗
15.09.2025Oncopeptides AB Stockholm
New shares (subscription)
4,628SEK 3.20
SEK 14,809.60
↗
15.09.2025Oncopeptides AB Stockholm
New shares (subscription)
222SEK 3.20
SEK 710.40
↗
26.08.2025Oncopeptides AB Stockholm
Bought — open marketAcquisition
1,000SEK 4.78
SEK 4,775.00
↗
26.08.2025Oncopeptides AB Stockholm
Bought — open marketAcquisition
1,000SEK 4.77
SEK 4,770.00
↗
25.08.2025Oncopeptides AB Stockholm
Bought — open marketAcquisition
3,500SEK 4.38
SEK 15,330.00
↗